Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Regular follow-up visits, especially with dermatologists, can lower death rates for melanoma patients, with socioeconomic factors also affecting outcomes.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Obesity is an independent risk factor for early coronary artery disease (CAD) and its severity is not affected by age.

Pancreatic cancer had a very low survival rate and was hard to treat effectively.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Older males had higher death rates, and Latin Americans were more often in the ICU during the COVID-19 outbreak in a Spanish hospital.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Hospital staff have a higher rate of hair loss than the general population.

The combination treatment showed a higher response rate but no significant survival benefits.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Platelet-rich plasma can help thicken the endometrium and improve pregnancy rates.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Not taking prescribed medications properly can lead to higher death rates from unrelated health conditions.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.